Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...
Sandoz launches biosimilar Pyzchiva in US, offering new treatment for around 12 million patients: Basel Tuesday, February 25, 2025, 14:00 Hrs [IST] Sandoz, the global leader in ge ...
The mass resignation of engineers, data scientists, and product managers is a temporary setback for Musk and the Republican ...
Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.
Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they ...
More than 20 civil service employees resigned Tuesday from Elon Musk’s Department of Government Efficiency, saying they ...
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
J&J said it is seeking a preliminary injunction for Samsung Bioepis' close copy of Stelara over an unauthorized sublicense ...
As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...
3h
Stockhead on MSNBiocurious: With Mayne Pharmaceuticals under takeover offer, who’s next?The ‘London’ Bus theory goes that if one takeover emerges in a particular sector, then others will follow in quick succession ...
Sen. Lisa Murkowski, R-Alaska, had some harsh words for the way DOGE was operating, calling the email sent to federal workers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results